Letters

Screening without evidence of efficacy

BMJ 2004; 328 doi: http://dx.doi.org/10.1136/bmj.328.7438.521-b (Published 26 February 2004) Cite this as: BMJ 2004;328:521

Summary of responses

  1. Birte Twisselmann, technical editor
  1. BMJ

    EDITOR—Law's editorial on screening without evidence of efficacy prompted a predictably substantial number of responses that were, perhaps not so predictably, mostly united in their agreement with his objections to advocating screening of unproved value.1 He concludes: “For a new drug a rigorous set of experimental data must be presented before it is licensed for use, and until it is licensed patients cannot obtain it. The same rigour should apply to medical screening.”

    Most of the responses questioned the value of screening and …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe